tiprankstipranks
Trending News
More News >
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
US Market

Compare Glenmark Pharmaceuticals Limited (GLENMARK) vs. Competitors

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Glenmark Pharmaceuticals Limited
₹2065.95
₹545.85B
54.31
32.95%
Alkem Laboratories Ltd.
₹5558.15
₹683.80B
28.65
11.92%
0 Buy
1 Hold
0 Sell
Hold
Aurobindo Pharma Ltd
₹1207.35
₹662.29B
19.03
-3.83%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biocon Limited
₹364.20
₹593.57B
91.81
-3.92%
2 Buy
0 Hold
1 Sell
Moderate Buy
GlaxoSmithKline Pharmaceuticals Limited
₹2483.35
₹384.52B
40.33
12.70%
Lupin Limited
₹1938.85
₹989.47B
22.58
1.24%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IN:GLENMARK
Glenmark Pharmaceuticals Limited
1,995.90
487.25
32.30%
IN:ALKEM
Alkem Laboratories Ltd.
5,765.40
635.01
12.38%
IN:AUROPHARMA
Aurobindo Pharma Ltd
1,145.60
-95.04
-7.66%
IN:BIOCON
Biocon Limited
372.65
-23.87
-6.02%
IN:GLAXO
GlaxoSmithKline Pharmaceuticals Limited
2,379.85
314.53
15.23%
IN:LUPIN
Lupin Limited
2,165.05
28.13
1.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts